Emotional intelligence training as a protective factor for mental health during the COVID-19 pandemic.


Journal

Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816

Informations de publication

Date de publication:
10 2021
Historique:
revised: 14 06 2021
received: 29 03 2021
accepted: 08 07 2021
pubmed: 23 7 2021
medline: 15 10 2021
entrez: 22 7 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has presented a major challenge to mental health and emotional wellbeing. The present study examined whether training in emotional intelligence (EI) skills, provided before the pandemic, would serve as a protective factor for sustaining mental health during the COVID-19 crisis. Data came from a longitudinal study (N = 89) that was initially designed to test the effectiveness of an EI training program versus a non-emotion-focused placebo program. The design and timing of the study were such that baseline and posttraining assessments of depression and anxiety had been completed before the pandemic, and planned 6-month follow-ups were serendipitously scheduled to occur after the onset of the COVID-19 crisis. This provided us with an unexpected real-world opportunity to investigate whether EI training would bolster emotional resilience to the challenges posed by the COVID-19 pandemic. Although mental health concerns generally increased after the start of the pandemic, individuals who completed the EI training program scored lower on depression, suicidal ideation, and state anxiety relative to individuals who had been assigned to the placebo training program. Online EI training appears to be effective at sustaining critical aspects of mental health during a subsequent real-life crisis.

Identifiants

pubmed: 34293205
doi: 10.1002/da.23202
pmc: PMC8427055
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1018-1025

Subventions

Organisme : U.S. Army Medical Research and Development Command
ID : W81XWH-16-1-0062

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Psychiatry Res. 2020 Aug;290:113117
pubmed: 32480121
J Clin Nurs. 2021 Feb;30(3-4):385-396
pubmed: 33145859
Psychol Rep. 2019 Jun;122(3):853-879
pubmed: 29699472
J Anxiety Disord. 2020 May;72:102232
pubmed: 32408047
Psychol Med. 2022 Apr;52(5):824-833
pubmed: 32571438
Psychol Med. 2021 Apr;51(6):1052-1053
pubmed: 32216863
J Abnorm Psychol. 1988 Aug;97(3):346-53
pubmed: 3192830
J Appl Psychol. 2010 Jan;95(1):54-78
pubmed: 20085406
J Urban Health. 2021 Feb;98(1):27-40
pubmed: 33259027
Int J Disaster Risk Reduct. 2020 Dec;51:101789
pubmed: 32834975
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Can J Psychiatry. 2021 Jan;66(1):9-13
pubmed: 32909832
J Vocat Behav. 2020 Jun;119:103439
pubmed: 32390658
J Health Psychol. 2022 Feb;27(2):268-277
pubmed: 32811195
J Clin Psychol. 2000 Apr;56(4):545-51
pubmed: 10775046
Psychiatry Res. 2020 Sep;291:113216
pubmed: 32544705
Depress Anxiety. 2021 Oct;38(10):1018-1025
pubmed: 34293205
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
Int J Environ Res Public Health. 2020 Sep 30;17(19):
pubmed: 33007892
Am Psychol. 2021 Jan;76(1):63-77
pubmed: 32772537
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S454-66
pubmed: 22588766
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Anxiety Disord. 2020 May;72:102231
pubmed: 32447204
PLoS One. 2020 Oct 21;15(10):e0241032
pubmed: 33085716
Front Psychiatry. 2021 Apr 22;12:561898
pubmed: 33967841
J Clin Psychol. 2013 Jun;69(6):630-45
pubmed: 23381685
J Intern Med. 2021 Apr;289(4):463-473
pubmed: 33164230
Front Psychiatry. 2021 Jan 22;11:589614
pubmed: 33551864
Pers Individ Dif. 2021 Jan 1;168:110348
pubmed: 32843781

Auteurs

Michelle R Persich (MR)

Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.

Ryan Smith (R)

Department of Psychiatry, Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.

Sara A Cloonan (SA)

Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.

Rebecca Woods-Lubbert (R)

Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.

Michael Strong (M)

Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.

William D S Killgore (WDS)

Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH